Drug Database
Back to search

United States· US:0093-5538_efcf4106-ac0a-4f8b-bcd0-743e45e66924

Eszopiclone

A eszopiclone product containing eszopiclone, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 10 of our 19 countries.

ATC N05CF04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEszopicloneATCN05CF04REGISTER NO.US:0093-5538_efcf4106…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eszopicloneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eszopiclone is registered in 10 of 19 countries.

Countries holding a registration under ATC N05CF04 (eszopiclone), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search eszopiclone products by name

Eszopiclone · ATC N05CF04

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eszopiclone costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Eszopiclone · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ESZOPICLONE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Country
United States (US)
ATC code
N05CF04
ATC class
Eszopiclone
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0093553801
    100 TABLET, FILM COATED in 1 BOTTLE (0093-5538-01)
  • ndc11
    0093-5538-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

126 interactions on record for eszopiclone.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eszopiclone against other medicinesHow interaction checks work

Eszopiclone · interactions on record

126 records

  • 13 severe
  • 113 moderate

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe
  • Darunavir and cobicistatJ05AR14severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eszopiclone in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eszopiclone products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Esogno
  • Bulgaria · Есогно
  • Czechia · Esogno
  • Germany · Esogno, Lunivia
  • Estonia · Esogno
  • France · Noxiben
  • Hungary · Esogno
  • Italy · Esnoxiben
  • Lithuania · Esogno
  • Latvia · Esogno
  • Poland · Esogno
  • Slovakia · Esogno

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/97c77deb-d261-4183-b0ae-fce93b3b0abb
GET /v1/drugs/97c77deb-d261-4183-b0ae-fce93b3b0abb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2",
  "substance": "ESZOPICLONE",
  "productndc": "0093-5538",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": "CIV",
  "strength_unit": "mg/1",
  "application_number": "ANDA091169",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about eszopiclone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console